As of May 2024 DBV Technologies has a market cap of $0.12 Billion. This makes DBV Technologies the world's 7263th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | -33.79% |
2023 | $0.19 B | -32.43% |
2022 | $0.28 B | 51.11% |
2021 | $0.19 B | -34.92% |
2020 | $0.29 B | -71.72% |
2019 | $1.03 B | 182.91% |
2018 | $0.36 B | -70.74% |
2017 | $1.24 B | -26.42% |
2016 | $1.69 B | -3.42% |
2015 | $1.75 B | 71.56% |
2014 | $1.02 B |
On May 4th, 2024 the market cap of DBV Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Ionis Pharmaceuticals
IONS | $6.12 B | 4,658.94% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 256.80% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $19.26 B | 14,875.73% | ๐บ๐ธ USA |